Logo image of AVXS

AVEXIS INC (AVXS) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:AVXS - US05366U1007

217.83
+0.18 (+0.08%)
Last: 5/14/2018, 8:00:00 PM
217.94
+0.11 (+0.05%)
Pre-Market: 5/15/2018, 8:24:29 AM

AVXS Key Statistics, Chart & Performance

Key Statistics
Market Cap8.02B
Revenue(TTM)N/A
Net Income(TTM)-410.43M
Shares36.82M
FloatN/A
52 Week High217.94
52 Week Low65.54
Yearly Dividend0
Dividend Yield0%
EPS(TTM)-12.34
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPON/A
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A


AVXS short term performance overview.The bars show the price performance of AVXS in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 20 40 60 80 100

AVXS long term performance overview.The bars show the price performance of AVXS in the last 1, 2 and 3 years. 1 year 2 years 3 years 50 100 150 200

The current stock price of AVXS is 217.83 null. In the past month the price increased by 3.35%. In the past year, price increased by 220.72%.

AVEXIS INC / AVXS Daily stock chart

About AVXS

Company Profile

AveXis, Inc. is a gene therapy company which develops and commercializes treatments for neurological genetic diseases primarily in United States. The Company's product candidate consists of AVXS-101 which is in clinical trial for the treatment of spinal muscular atrophy Type 1, the genetic cause of infant mortality. AveXis, Inc. is headquartered in Bannockburn, Illinois.

Company Info

AVEXIS INC

2275 HALF DAY ROAD SUIT 200

BANNOCKBURN IL 60015

CEO: Sean P. Nolan

Phone: 847-572-8280

AVEXIS INC / AVXS FAQ

What does AVXS do?

AveXis, Inc. is a gene therapy company which develops and commercializes treatments for neurological genetic diseases primarily in United States. The Company's product candidate consists of AVXS-101 which is in clinical trial for the treatment of spinal muscular atrophy Type 1, the genetic cause of infant mortality. AveXis, Inc. is headquartered in Bannockburn, Illinois.


What is the stock price of AVEXIS INC today?

The current stock price of AVXS is 217.83 null. The price increased by 0.08% in the last trading session.


What is the dividend status of AVEXIS INC?

AVXS does not pay a dividend.


What is the ChartMill rating of AVEXIS INC stock?

AVXS has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Can you provide the market cap for AVEXIS INC?

AVEXIS INC (AVXS) has a market capitalization of 8.02B null. This makes AVXS a Mid Cap stock.


AVXS Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to AVXS. When comparing the yearly performance of all stocks, AVXS is one of the better performing stocks in the market, outperforming 98.9% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

AVXS Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to AVXS. AVXS has a great financial health rating, but its profitability evaluates not so good.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AVXS Financial Highlights

Over the last trailing twelve months AVXS reported a non-GAAP Earnings per Share(EPS) of -12.34. The EPS decreased by -98.37% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -61.51%
ROE -72.09%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-479.44%
Sales Q2Q%N/A
EPS 1Y (TTM)-98.37%
Revenue 1Y (TTM)N/A

AVXS Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next Y-33.1%
Revenue Next YearN/A

AVXS Ownership

Ownership
Inst Owners84.14%
Ins Owners0.96%
Short Float %N/A
Short RatioN/A